IP Library Assignment 026557/0373
Patent Assignment
Reel/Frame 026557/0373

Security Agreement

Recorded: 2011-07-07 Pages: 10
Assignor
Assignee
MORGAN STANLEY SENIOR FUNDING, INC., AS ADMINISTRATIVE AGENT
1 PIERREPONT PLAZA, BROOKLYN, NEW YORK, 11201
Covered Properties (46)
Platelet Activating Factor Antagonist and Methods of Use Therefor
Patent: 4,973,603 →
Application: 07/350,391 →
Preparation of Homogeneous Hydrogel Copolymers
Patent: 5,266,325 →
Application: 07/621,346 →
Manufacture of Water-Swellable Hydrophilic Articles and Drug Delivery Devices
Patent: 5,292,515 →
Application: 08/041,523 →
Compound for Inhibiting Hiv Infectivity
Patent: 5,614,559 →
Application: 08/245,619 →
Efficient Method to Conduct Large-Scale Genome Sequencing
Patent: 5,670,321 →
Application: 08/438,567 →
Compound for Inhibiting Hiv Infectivity
Patent: 5,677,343 →
Application: 08/467,725 →
Compound for Inhibiting Hiv Infectivity
Patent: 6,075,050 →
Application: 08/467,728 →
Sulfonic Acid and Aldehyde Condensation Polymers for Preventing Pregnancy
Patent: 5,958,399 →
Application: 08/847,019 →
Compound for Inhibiting Hiv Infectivity
Patent: 6,365,625 →
Application: 09/398,571 →
Methods and Compositions for Alleviating Stuttering
Patent: 6,855,721 →
Application: 09/628,803 →
Hydrogel compositions useful for the sustained release of macromolecules and methods of making same
Patent: 6,361,797 →
Application: 09/646,066 →
Methods of Treating Obsessive-Compulsive Disorder
Patent: 7,026,332 →
Application: 10/133,471 →
Publication: US 2003/0022915
Methods for Making 2-(7-Chloro-1,8-Naphthyridine-2-Yl)-3-(5-Methyl-2-Oxo-Hexyl)-1-Isoindolinone
Patent: 6,949,653 →
Application: 10/400,780 →
Publication: US 2003/0191315
Implanting Device and Method of Using Same
Patent: 7,214,206 →
Application: 10/406,397 →
Publication: US 2004/0199140
Long Term Drug Delivery Devices with Polyurethane Based Polymers and Their Manufacture
Patent: 7,842,303 →
Application: 10/915,625 →
Publication: US 2005/0037078
Methods and Compositions for Alleviating Stuttering
Patent: 7,858,638 →
Application: 11/046,706 →
Publication: US 2005/0256029
Compositions and Methods for Treating Precocious Puberty
Patent: 8,062,652 →
Application: 11/155,822 →
Publication: US 2006/0019903
Methods for Making 2-(7-Chloro-1,8-Naphthyridine-2-Yl)-3-(5-Methyl-2OXO-Hexyl)-1-Isoidolinone
Patent: 7,057,047 →
Application: 11/206,144 →
Publication: US 2005/0288322
Use of Pagoclone for the Treatment of Social Anxiety Disorder
Patent: 7,553,847 →
Application: 11/352,286 →
Publication: US 2006/0128746
Controlled Release Formulations of Octreotide
Patent: 7,452,868 →
Application: 11/372,749 →
Publication: US 2006/0204540
Method for Making 2-(7-Chloro-1,8-Naphthyridine-2-Yl)-3-(5-Methyl-2-Oxo-Hexyl)-1-Isoindolinone)
Patent: 7,304,158 →
Application: 11/411,952 →
Publication: US 2006/0194830
Method of Inserting an Object Under the Skin
Patent: 7,510,549 →
Application: 11/531,311 →
Publication: US 2007/0073265
Implant Device Release Agents and Methods of Using Same
Patent: 9,120,249 →
Application: 12/109,852 →
Publication: US 2008/0311170
Delivery of Dry Formulations of Octreotide
Patent: 7,759,312 →
Application: 12/171,999 →
Publication: US 2009/0035343
Controlled Release Formulations of Octreotide
Patent: 7,803,773 →
Application: 12/240,690 →
Publication: US 2009/0087470
Long Term Drug Delivery Devices with Polyurethane Based Polymers and Their Manufacture
Patent: 7,858,110 →
Application: 12/242,497 →
Publication: US 2009/0098182
Compositions and Methods for the Treatment of Bladder Cancer
Application: 12/324,019 →
Publication: US 2009/0214634
Implantable Device for the Delivery of Naltrexone and Methods of Use Thereof
Application: 12/351,617 →
Publication: US 2009/0208540
Sulfonic Acid and Aldehyde Condensation Polymers for the Treatment and Prevention of Hpv
Patent: 8,604,086 →
Application: 12/393,778 →
Publication: US 2009/0247639
Combination Treatment for Bladder Cancer
Patent: 8,273,721 →
Application: 12/397,831 →
Publication: US 2009/0227529
Implantation Device for Subcutaneous Implatation of an Object Under the Skin
Patent: 7,850,639 →
Application: 12/415,681 →
Publication: US 2009/0247939
An Implantable Device for the Sustained Release of a Polypeptide
Patent: 8,071,537 →
Application: 12/490,971 →
Publication: US 2010/0021522
Octreotide Implant Having a Release Agent and Uses Thereof
Patent: 7,960,335 →
Application: 12/490,979 →
Publication: US 2010/0022450
Implantable Device for the Delivery of Risperidone and Methods of Use Thereof
Patent: 9,078,900 →
Application: 12/569,558 →
Publication: US 2010/0080835
Controlled Release Formulations of Octreotide
Application: 12/814,276 →
Publication: US 2011/0009338
Delivery of Dry Formulations of Octreotide
Application: 12/814,286 →
Publication: US 2010/0247594
Controlled Release Formulations of Octreotide
Patent: 8,507,432 →
Application: 12/814,293 →
Publication: US 2010/0317579
A Method of Manufacturing an Implantable Device
Patent: 8,475,820 →
Application: 12/844,357 →
Publication: US 2010/0292144
Long Term Drug Delivery Devices with Polyurethane Based Polymers and Their Manufacture
Patent: 8,357,389 →
Application: 12/873,130 →
Publication: US 2011/0059147
Long Term Drug Delivery Devices with Polyurethane Based Polymers and Their Manufacture
Patent: 8,343,528 →
Application: 12/907,717 →
Publication: US 2011/0034566
Long Term Drug Delivery Devices with Polyurethane-Based Polymers and Their Manufacture
Patent: 8,303,977 →
Application: 12/912,655 →
Publication: US 2011/0184376
Methods and Compositions for Alleviating Stuttering
Patent: 8,242,132 →
Application: 12/973,515 →
Publication: US 2011/0184012
Octreotide Implant Having a Release Agent
Patent: 8,383,577 →
Application: 13/098,138 →
Publication: US 2011/0206745
Implantable Device for the Delivery of Octreotide and Methods of Use Thereof
Application: 13/121,152 →
Publication: US 2011/0244015
Implantable Device for the Delivery of Histrelin and Methods of Use Thereof
Application: 13/121,391 →
Publication: US 2011/0236456
Implanting Device
Patent: 492,995 →
Application: 29/179,382 →
Related Assignments (25)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Apr 27, 2006
From: WARNER LAMBERT COMPANY LLC (FORMERLY KNOWN AS WARNER-LAMBERT COMPANY)
To: INDEVUS PHARMACEUTICALS, INC.
Reel/Frame 019931/0393 →
Assignment of Assignor's Interest Apr 27, 2006
From: JENNINGS, SANDRA MARIE; STUK, TIMOTHY LEE
To: WARNER-LAMBERT COMPANY
Reel/Frame 017834/0508 →
Assignment of Assignor's Interest Sep 11, 2007
From: VALERA PHARMACEUTICALS, INC.
To: INDEVUS PHARMACEUTICALS, INC.
Reel/Frame 019805/0605 →
Assignment of Assignor's Interest Sep 11, 2007
From: VALERA PHARMACEUTICALS, INC.
To: INDEVUS PHARMACEUTICALS, INC.
Reel/Frame 019805/0317 →
Assignment of Assignor's Interest Sep 11, 2007
From: VALERA PHARMACEUTICALS, INC.
To: INDEVUS PHARMACEUTICALS, INC.
Reel/Frame 019805/0464 →
Assignment of Assignor's Interest Sep 11, 2007
From: VALERA PHARMACEUTICALS, INC.
To: INDEVUS PHARMACEUTICALS, INC.
Reel/Frame 019805/0475 →
Assignment of Assignor's Interest Jan 9, 2008
From: VALERA PHARMACEUTICALS, INC.
To: INDEVUS PHARMACEUTICALS, INC.
Reel/Frame 020342/0595 →
Merger Jan 23, 2008
From: VALERA PHARMACEUTICALS, INC.
To: INDEVUS PHARMACEUTICALS, INC.
Reel/Frame 020404/0071 →
Corrective Assignment to Correct the Patent Number, Serial Number, Filing Date, and Issue Date. Previously Recorded on Reel 022151 Frame 0332. Assignor(S) Hereby Confirms the Please Change Patent No. from "6,670,320" to --5,670,321--.. Jan 28, 2009
From: PROGENITOR, INC.
To: INDEVUS PHARMACEUTICALS, INC.
Reel/Frame 022162/0207 →
Change of Name Oct 2, 2009
From: INDEVUS PHARMACEUTICALS INC.
To: ENDO PHARMACEUTICALS SOLUTIONS INC.
Reel/Frame 023312/0681 →
Security Agreement Oct 19, 2009
From: ENDO PHARMACEUTICALS SOLUTIONS INC.
To: JPMORGAN CHASE BANK, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 023390/0220 →
Security Agreement Dec 1, 2010
From: ENDO PHARMACEUTICALS SOLUTIONS INC.
To: JPMORGAN CHASE BANK, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 025434/0842 →
Release of Patent Security Interest Recorded at Reel/Frame 23390/220 Dec 3, 2010
From: JPMORGAN CHASE BANK, N.A., AS ADMINISTRATIVE AGENT
To: ENDO PHARMACEUTICALS SOLUTIONS INC.
Reel/Frame 025441/0710 →
Release of Security Interest Recorded at Reel/Frame 25434/842 Jul 11, 2011
From: JPMORGAN CHASE BANK N.A., AS ADMINISTRATIVE AGENT
To: ENDO PHARMACEUTICALS SOLUTIONS INC.
Reel/Frame 026571/0616 →
Change of Name Feb 27, 2014
From: PROCEPT, INC.
To: HEAVENLYDOOR.COM, INC.
Reel/Frame 032366/0915 →
Merger and Change of Name Feb 27, 2014
From: HEAVENLYDOOR.COM, INC.
To: PALIGENT INC.
Reel/Frame 032366/0904 →
Release of Patent Security Interest Mar 3, 2014
From: MORGAN STANLEY SENIOR FUNDING, INC., AS ADMINISTRATIVE AGENT
To: ENDO PHARMACEUTICALS SOLUTIONS INC.
Reel/Frame 032380/0226 →
Grant of Security Interest in Patents Mar 20, 2014
From: ENDO PHARMACEUTICALS SOLUTIONS, INC.; ENDO PHARMACEUTICALS, INC.; AMS RESEARCH CORPORATION; AMERICAN MEDICAL SYSTEMS, INC.
To: DEUTSCHE BANK AG NEW YORK BRANCH, AS COLLATERAL AGENT
Reel/Frame 032491/0440 →
Assignment of Assignor's Interest Nov 19, 2014
From: ENDO PHARMACEUTICALS SOLUTIONS INC.
To: BRAEBURN PHARMACEUTICALS BVBA SPRL
Reel/Frame 034206/0253 →
Assignment of Assignor's Interest Jun 3, 2016
From: BRAEBURN PHARMACEUTICALS BVBA SPRL
To: BRAEBURN PHARMACEUTICALS, INC.
Reel/Frame 038800/0527 →
Assignment of Assignor's Interest Jan 25, 2017
From: ENDO PHARMACEUTICALS SOLUTIONS INC.; ENDO PHARMACEUTICALS VALERA INC.
To: BRAEBURN PHARMACEUTICALS, INC.
Reel/Frame 041081/0926 →
Assignment of Assignor's Interest Jan 30, 2017
From: VALERA PHARMACEUTICALS, INC.
To: INDEVUS PHARMACEUTICALS, INC.
Reel/Frame 041123/0514 →
Change of Name Jan 30, 2017
From: VALERA PHARMACEUTICALS, INC.
To: ENDO PHARMACEUTICALS VALERA INC.
Reel/Frame 041564/0401 →
Release of Security Interest Feb 3, 2017
From: DEUTSCHE BANK AG NEW YORK BRANCH
To: ENDO PHARMACEUTICALS SOLUTIONS INC.
Reel/Frame 041171/0936 →
Release of Security Interest Apr 28, 2017
From: DEUTSCHE BANK AG NEW YORK BRANCH
To: ENDO PHARMACEUTICALS, INC.; ENDO PHARMACEUTICALS SOLUTIONS, INC.; ASTORA WOMEN'S HEALTH HOLDINGS, LLC
Reel/Frame 042362/0001 →